Breathe Well Live Well
Condition: Asthma
Interventions: Drug: MK-1029 150 mg; Drug: Placebo for MK-1029; Drug: Montelukast 10 mg; Drug: Albuterol/Salbutamol 90 mcg – 100 mcg per inhalation
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting – verified March 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention:
Sponsors: University of North Carolina, Chapel Hill; American Academy of Allergy, Asthma, and Immunology
Recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Asthma: A Persistent Threat
KQED Twenty-five million Americans — including 1 in 10 children — have asthma, according to the Centers for Disease Control. But even as treatments for asthma have improved, total numbers of those affected by the chronic disease haven't declined over the … |
View full post on asthma – Google News
Condition: Persistent Asthma
Interventions: Drug: Beclomethasone Dipropionate; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Asthma Exacerbations
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Inner City Asthma Consortium (ICAC)
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Vilanterol; Drug: Fluticasone propionate; Drug: Salmeterol; Drug: Budesonide; Drug: Formoterol Fumarate
Sponsor: GlaxoSmithKline
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Placebo; Drug: BI 655066
Sponsor: Boehringer Ingelheim
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Marketed antagonists
Sponsor: Teva Pharmaceuticals Europe
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days